SCN2A mutation in a Chinese boy with infantile spasm - response to Modified Atkins Diet

Virginia C N Wong1, C W Fung1, Anna K Y Kwong2

  • 1Division of Paediatric Neurology/Developmental Behavioural Paediatrics/NeuroHabilitation, Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong Special Administrative Region, China; Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.

Brain & Development
|December 3, 2014
PubMed

Insights

A novel SCN2A gene mutation, E1211K, was identified in a Chinese boy with severe infantile spasms (IS). This finding highlights SCN2A mutations as a key cause of IS and suggests the Modified Atkins Diet may be beneficial.

Area of Science:

  • Genetics
  • Neurology
  • Epileptology

Background:

  • SCN2A gene mutations are linked to diverse epilepsy types, including infantile spasms (IS).
  • Voltage-gated sodium channels are crucial for neuronal function and implicated in epilepsy pathogenesis.

Observation:

  • A 6-year-old Chinese boy presented with severe developmental delay, infantile spasms from 15 months, intellectual disability, and autistic features.
  • The patient exhibited drug-resistant epilepsy but achieved seizure remission with the Modified Atkins Diet.

Findings:

  • A heterozygous SCN2A mutation (c.3631G>A; p.E1211K) was identified, previously reported only in a Japanese IS patient.
  • This marks the first identification of an SCN2A mutation in a Chinese individual with IS.

Implications:

  • The E1211K mutation in SCN2A is a significant potential etiology for infantile spasms.
  • Investigating the Modified Atkins Diet for infantile spasm patients with similar SCN2A mutations warrants further research.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
2